Heart Test Laboratories

HSCS

Market cap $8.5M

HSCS Hedge Fund Activity: Q1 2026 in Review

13 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in Heart Test Laboratories (HSCS) for Q1 2026, worth a combined $539K — down 12% from $610K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new HSCS positions and 1 closed out — a net gain of 4 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Tradition Wealth Management, opening a new position worth an estimated $49K. The largest seller was DRW Securities, cutting an estimated $54.2K.

• 13 institutional investors held Heart Test Laboratories (HSCS) as of Q1 2026, up from 10 in Q4 2025.
• Funds reported $539K of Heart Test Laboratories stock for Q1 2026, down 12% quarter-over-quarter.
• 5 funds opened new Heart Test Laboratories positions in Q1 2026 and 1 closed out, a net change of +4 holders.
• The largest Heart Test Laboratories buyer in Q1 2026 was Tradition Wealth Management, an estimated $49K added.
• The largest Heart Test Laboratories seller in Q1 2026 was DRW Securities, an estimated $54.2K sold.

Based on aggregated 13F filings for Q1 2026.